Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytokines and Metallopeptidases in Lumbar Disc Herniation Treatments
NCT06545812Completed
- Sponsor
- Josip Juraj Strossmayer University of Osijek
- Start
- Sep 2024
- Primary completion
- Mar 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of methylprednisolone, levobupivacaine and lidocaine in intervertebral disc herniation (2 arms), sponsored by Josip Juraj Strossmayer University of Osijek. Primary endpoint: Serum concentrations of pro-inflammatory and anti-inflammatory cytokines and metallopeptidases at 3 months. Started Sep 2024; status: completed.
02
Drugs
methylprednisolonelevobupivacainelidocaine
03
Conditions
intervertebral disc herniation
Beyond the preview
Go deeper on NCT06545812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06545812.